Zevra appoints Timothy Sangiovanni as interim CFO effective Jan 1, 2026

ZEVRA THERAPEUTICS, INC.

Timothy Sangiovanni named interim principal financial officer, effective January 1, 2026.
Sangiovanni currently serves as SVP Finance and Corporate Controller; joined company in 2015.
No change in compensation arrangements in connection with the appointment.
No information provided on predecessor's departure or timing of permanent CFO search.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.